Glucomannan containing pharmaceutical compositions with extended release and abuse deterrent properties

A pharmaceutical composition comprising at least one active pharmaceutical ingredient (API) or a pharmaceutically acceptable salt thereof, a glucomannan, a first polyalkylene oxide having an average molecular weight of no more than 300,000, and a second polyalkylene oxide having an average molecular...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Gower, Brad L, Herman, Clifford J, Lai, Tsz Chung, Park, Jae Han, Feng, Kai
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator Gower, Brad L
Herman, Clifford J
Lai, Tsz Chung
Park, Jae Han
Feng, Kai
description A pharmaceutical composition comprising at least one active pharmaceutical ingredient (API) or a pharmaceutically acceptable salt thereof, a glucomannan, a first polyalkylene oxide having an average molecular weight of no more than 300,000, and a second polyalkylene oxide having an average molecular weight of at least 1,000,000 and methods of making. The pharmaceutical composition extended release of the API and has abuse deterrent features.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_AU2017216904BB2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>AU2017216904BB2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_AU2017216904BB23</originalsourceid><addsrcrecordid>eNqNjTsOwjAQBdNQIOAOW9AiJQGBKAnicwCo0WI_EkvO2rI3guOTggNQvZFmpDct2osfTOhZhIVMEGUnTlqKHaeeDQZ1hv1o-hiyUxck09tpR_goxMJSggdnEIslfg4jWShSgijFFCKSOuR5MXmxz1j8dlYsz6fb8bpCDA_kOF4J9HG412W1q6vtvtw0Tb3-M_sCDKJCug</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Glucomannan containing pharmaceutical compositions with extended release and abuse deterrent properties</title><source>esp@cenet</source><creator>Gower, Brad L ; Herman, Clifford J ; Lai, Tsz Chung ; Park, Jae Han ; Feng, Kai</creator><creatorcontrib>Gower, Brad L ; Herman, Clifford J ; Lai, Tsz Chung ; Park, Jae Han ; Feng, Kai</creatorcontrib><description>A pharmaceutical composition comprising at least one active pharmaceutical ingredient (API) or a pharmaceutically acceptable salt thereof, a glucomannan, a first polyalkylene oxide having an average molecular weight of no more than 300,000, and a second polyalkylene oxide having an average molecular weight of at least 1,000,000 and methods of making. The pharmaceutical composition extended release of the API and has abuse deterrent features.</description><language>eng</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2021</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20211118&amp;DB=EPODOC&amp;CC=AU&amp;NR=2017216904B2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25543,76293</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20211118&amp;DB=EPODOC&amp;CC=AU&amp;NR=2017216904B2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Gower, Brad L</creatorcontrib><creatorcontrib>Herman, Clifford J</creatorcontrib><creatorcontrib>Lai, Tsz Chung</creatorcontrib><creatorcontrib>Park, Jae Han</creatorcontrib><creatorcontrib>Feng, Kai</creatorcontrib><title>Glucomannan containing pharmaceutical compositions with extended release and abuse deterrent properties</title><description>A pharmaceutical composition comprising at least one active pharmaceutical ingredient (API) or a pharmaceutically acceptable salt thereof, a glucomannan, a first polyalkylene oxide having an average molecular weight of no more than 300,000, and a second polyalkylene oxide having an average molecular weight of at least 1,000,000 and methods of making. The pharmaceutical composition extended release of the API and has abuse deterrent features.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2021</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNjTsOwjAQBdNQIOAOW9AiJQGBKAnicwCo0WI_EkvO2rI3guOTggNQvZFmpDct2osfTOhZhIVMEGUnTlqKHaeeDQZ1hv1o-hiyUxck09tpR_goxMJSggdnEIslfg4jWShSgijFFCKSOuR5MXmxz1j8dlYsz6fb8bpCDA_kOF4J9HG412W1q6vtvtw0Tb3-M_sCDKJCug</recordid><startdate>20211118</startdate><enddate>20211118</enddate><creator>Gower, Brad L</creator><creator>Herman, Clifford J</creator><creator>Lai, Tsz Chung</creator><creator>Park, Jae Han</creator><creator>Feng, Kai</creator><scope>EVB</scope></search><sort><creationdate>20211118</creationdate><title>Glucomannan containing pharmaceutical compositions with extended release and abuse deterrent properties</title><author>Gower, Brad L ; Herman, Clifford J ; Lai, Tsz Chung ; Park, Jae Han ; Feng, Kai</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_AU2017216904BB23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2021</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>Gower, Brad L</creatorcontrib><creatorcontrib>Herman, Clifford J</creatorcontrib><creatorcontrib>Lai, Tsz Chung</creatorcontrib><creatorcontrib>Park, Jae Han</creatorcontrib><creatorcontrib>Feng, Kai</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Gower, Brad L</au><au>Herman, Clifford J</au><au>Lai, Tsz Chung</au><au>Park, Jae Han</au><au>Feng, Kai</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Glucomannan containing pharmaceutical compositions with extended release and abuse deterrent properties</title><date>2021-11-18</date><risdate>2021</risdate><abstract>A pharmaceutical composition comprising at least one active pharmaceutical ingredient (API) or a pharmaceutically acceptable salt thereof, a glucomannan, a first polyalkylene oxide having an average molecular weight of no more than 300,000, and a second polyalkylene oxide having an average molecular weight of at least 1,000,000 and methods of making. The pharmaceutical composition extended release of the API and has abuse deterrent features.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_AU2017216904BB2
source esp@cenet
subjects HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
title Glucomannan containing pharmaceutical compositions with extended release and abuse deterrent properties
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-26T08%3A03%3A05IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Gower,%20Brad%20L&rft.date=2021-11-18&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EAU2017216904BB2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true